31.01.2013 - AstraZeneca's new boss warned on Thursday the drugmaker faced a tough year in 2013, with sales expected to fall by a mid-to-high single digit percentage rate as patent expiries...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)
